Crossreactivity of T Cells In Human Virus Infections

人类病毒感染中 T 细胞的交叉反应

• 批准号: 8367072
• 负责人: Liisa Kaarina Selin
• 金额: $ 30.24万
• 依托单位: UNIV OF MASSACHUSETTS MED SCH WORCESTER
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-05-24 至 2017-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8367072
• 关键词: Acute; Address; Adult; Adverse effects; Aging; Animal Model; Antigens; Arenavirus; CD8B1 gene; Cells; Dengue; Development; Disease Outcome; Elderly; Epitopes; Epstein-Barr Virus Infections; Equilibrium; Evolution; Excision; Frequencies; Generations; HLA-A2 Antigen; Hepatitis C; Hepatitis C virus; Human; Human Herpesvirus 4; Human Virus; Immune; Immune system; Immunity; Individual; Infection; Infectious Mononucleosis; Influenza; Instruction; Lead; Ligands; Lung; Maintenance; Mediating; Memory; Murid herpesvirus 1; Pathogenesis; Pathology; Patients; Peptides; Public Health; Research Personnel; Role; Severities; System; T cell response; T memory cell; T-Lymphocyte; Testing; Therapeutic Intervention; Vaccine Therapy; Vaccines; Vaccinia; Vaccinia virus; Vaccinium; Viral; Viral Load result; Virus; Virus Diseases; cross reactivity; design; immunopathology; insight; mouse model; pathogen; prevent; response

A comprehensive understanding of the mechanisms associated with the generation and modulation of immunological T cell memory will lead to a better understanding of how the immune system controls viral infections but also causes immune-mediated pathology. Heterologous immunity occurring as a consequence of T cell cross-reactivity (XR) between unrelated pathogens, such as influenza A (lAV), vaccinia virus, arenaviruses, and murine cytomegalovirus, has been shown by us with animal models to contribute to reduced (beneficial) or enhanced viral loads, and remarkably altered immunopathology (detrimental). We have demonstrated heterologous immunity in human infections with Epstein-Barr virus (EBV), while other investigators have demonstrated its role in influenza, dengue, and hepatitis C viruses. We have identified networks of cross-reactive T cells, which interact with EBV-BMLFI280 in HLA-A2+ patients with acute infectious mononucleosis (AIM) and directly correlated the severity of AIM with the frequency of memory influenza A Miss-specific CD8 T cells cross-reactive with EBV-epitopes. The cross-reactive repertoire appears broader than the non-cross-reactive repertoire to either antigen alone. We have evidence in five EBV-seronegative healthy donors that a unique cross-reactivity between lAV Ml-specific responses and EBV epitopes maybe protective. The overall objective of this proposal is to determine how T cell cross- reactivity impacts T cell selection and function, and changes disease outcome, to the worse or better, as the host is exposed to subsequent acute or persistent infections such as EBV. Insights on these issues are necessary for the intelligent design of modern vaccines that are effective and without unwanted side effects and to develop therapeutic interventions when virus infection induces immunopathology. We are one of the few groups studying heterologous immunity in viral systems and propose to clarify these issues in the following aims: 1) examine the mechanisms which control the balance between protective immunity versus pathology in heterologous immunity during EBV infection; 2) examine how XR TcR repertoires influence heterologous protective immunity and immunopathology; 3) test the hypothesis that elderly individuals have increased crossreactive responses due to heterologous infections. RELEVANCE (See instructions): These studies address public health-relevant questions such as can one design successful T cell vaccines that will give protection without pathology and under what circumstances do viruses induce severe pathology and are there ways to circumvent it? These studies open new avenues for the development of individualized therapies and vaccines if cross-reactive epitopes are identified or broad spectrum therapy in their absence.

的产生和调节相关的机制的全面了解